T1	Treatment 0 8	Oxytocin
T2	Treatment 85 93	oxytocin
T3	Treatment 148 156	Oxytocin
T4	Treatment 250 258	oxytocin
T5	Treatment 422 440	placebo-controlled
T6	Treatment 460 499	single-dose intranasal oxytocin (24 IU)
T7	Treatment 547 563	oxytocin/placebo
T8	Treatment 574 636	selected breakfast from a menu and were given double portions.
T9	Treatment 637 683	Caloric content of food consumed was measured.
T10	Treatment 684 704	Visual analog scales
T11	Treatment 739 844	blood was drawn for appetite-regulating hormones, insulin, and glucose before and after oxytocin/placebo.
T12	Treatment 845 934	Indirect calorimetry assessed resting energy expenditure (REE) and substrate utilization.
T13	Treatment 943 951	Oxytocin
T14	Treatment 1187 1195	Oxytocin
T15	Treatment 1310 1318	oxytocin
T16	Treatment 1456 1464	oxytocin
